Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures

[1]  S. Bär,et al.  Parvovirus interference with intracellular signalling: mechanism of PKCη activation in MVM‐infected A9 fibroblasts , 2008, Cellular microbiology.

[2]  P. Tattersall,et al.  Replication Initiator Protein NS1 of the Parvovirus Minute Virus of Mice Binds to Modular Divergent Sites Distributed throughout Duplex Viral DNA , 2007, Journal of Virology.

[3]  J. Rommelaere,et al.  A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells , 2007, Proceedings of the National Academy of Sciences.

[4]  M. Aprahamian,et al.  Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model. , 2007, Oncology reports.

[5]  M. Vähä-Koskela,et al.  Oncolytic viruses in cancer therapy , 2007, Cancer Letters.

[6]  J. Rommelaere,et al.  Cytosolic Activation of Cathepsins Mediates Parvovirus H-1-Induced Killing of Cisplatin and TRAIL-Resistant Glioma Cells , 2007, Journal of Virology.

[7]  T. Cripe,et al.  Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses , 2005, Cancer Gene Therapy.

[8]  C. Herold-Mende,et al.  Parvovirus H‐1 infection of human glioma cells leads to complete viral replication and efficient cell killing , 2004, International journal of cancer.

[9]  J. Jauniaux,et al.  Chimeric and Pseudotyped Parvoviruses Minimize the Contamination of Recombinant Stocks with Replication-Competent Viruses and Identify a DNA Sequence That Restricts Parvovirus H-1 in Mouse Cells , 2003, Journal of Virology.

[10]  T. Bashir,et al.  In Vivo Accumulation of Cyclin A and Cellular Replication Factors in Autonomous Parvovirus Minute Virus of Mice-Associated Replication Bodies , 2001, Journal of Virology.

[11]  P. Galle,et al.  Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors , 2001, Cancer Gene Therapy.

[12]  J. Rommelaere,et al.  Activation of Promoter P4 of the Autonomous Parvovirus Minute Virus of Mice at Early S Phase Is Required for Productive Infection , 1999, Journal of Virology.

[13]  M. Coffey,et al.  Reovirus therapy of tumors with activated Ras pathway. , 1998, Science.

[14]  J. Cesbron,et al.  Dose‐dependent regression of HeLa cell‐derived tumours in SCID mice after parvovirus H‐1 infection , 1998, International journal of cancer.

[15]  G. Leclercq,et al.  Varying sensitivity of human mammary carcinoma cells to the toxic effect of parvovirus H-1. , 1997, European journal of cancer.

[16]  R. Wattiez,et al.  The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins , 1997, Journal of virology.

[17]  A. Fattaey,et al.  An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells , 1996, Science.

[18]  R. Martuza,et al.  Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas , 1995, Nature Medicine.

[19]  J. Jauniaux,et al.  Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells , 1995, Journal of virology.

[20]  A. Bardelli,et al.  The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. , 1995, Oncogene.

[21]  J. Rommelaere,et al.  Targeting of promoters for trans activation by a carboxy-terminal domain of the NS-1 protein of the parvovirus minute virus of mice , 1994, Journal of virology.

[22]  D. Larsimont,et al.  Parvovirus H‐1 inhibits growth of short‐term tumor‐derived but not normal mammary tissue cultures , 1993, International journal of cancer.

[23]  D M Coen,et al.  Experimental therapy of human glioma by means of a genetically engineered virus mutant , 1991, Science.

[24]  J. Rommelaere,et al.  Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non‐structural proteins. , 1990, The EMBO journal.

[25]  P. Tattersall,et al.  Susceptibility of human cells to killing by the parvoviruses H-1 and minute virus of mice correlates with viral transcription , 1990, Journal of virology.

[26]  T. Dupressoir,et al.  Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. , 1989, Cancer research.

[27]  N. Fusenig,et al.  Sensitization of human keratinocytes to killing by parvovirus H-1 takes place during their malignant transformation but does not require them to be tumorigenic. , 1989, Carcinogenesis.

[28]  M. Namba,et al.  Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice , 1988, Journal of virology.

[29]  J. Rommelaere,et al.  Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1. , 1986, Cancer research.

[30]  G. Siegl.  Biology and Pathogenicity of Autonomous Parvoviruses , 1984 .

[31]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[32]  A. Levin,et al.  H-1 Virus Viremia in the Human.∗ , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.